2024
|
Invention
|
Homoplasmization promoter and use thereof. The present invention addresses the problem of providi... |
2021
|
Invention
|
Method for producing naive human ips cells from somatic cells.
Provided is a method for producin... |
|
Invention
|
Method for producing naive human ips cells from somatic cells. Provided is a method for producing... |
|
Invention
|
Quality improving agent for ips cells, method of producing ips cells, ips cells, and composition ... |
2020
|
Invention
|
Method for producing cardiomyocyte.
A method for producing a cardiomyocyte including preparing a... |
|
Invention
|
Method for producing cardiac muscle cells. This method for producing cardiac muscle cells compris... |
|
Invention
|
Insulin secretion promoting peptide. The present invention provides a peptide that promotes insul... |
2019
|
Invention
|
Supernatant of brown adipocytes, method for preparing same and utilization thereof.
The present ... |
|
Invention
|
Supernatant of brown adipocytes, method for preparing same and utilization thereof. Provided is a... |
|
Invention
|
System for highly efficient modification of target sequences. Provided is a technology for more e... |
|
Invention
|
Selective cd8-positive t cell-inducing vaccine antigen.
The present invention provides polypepti... |
|
Invention
|
Selective cd8-positive t cell-inducing vaccine antigen. A polypeptide for selectively inducing a ... |
2018
|
Invention
|
Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with rna vi... |
|
Invention
|
Nerve cell production method.
Provided is a nerve cell production method including preparing ste... |
|
Invention
|
Method for producing neural cells. Provided is a method for producing neural cells, the method in... |
|
P/S
|
Protein in raw material form for scientific and medical research; enzymes for scientific and medi... |
|
Invention
|
Polynucleotide for modifying target sequence and use thereof. The present invention provides a no... |
|
Invention
|
Composition for treating cancer. [Problem] To provide a composition for treating cancer, which ha... |
2017
|
Invention
|
Infectious disease vaccine using non-infectious paramyxovirus particle. In this invention, a non-... |
|
Invention
|
Production and use of motor neuron derived from pluripotent stem cell. The present invention prov... |
|
Invention
|
Genetically stable replication competent sendai virus vector(s) containing and expressing optimiz... |
2016
|
Invention
|
Paramyxovirus vector. An objective of the present invention is to provide an improved negative-st... |
|
Invention
|
Improved paramyxovirus vector. An objective of the present invention is to provide an improved ne... |
|
Invention
|
Mycobacterium tuberculosis vaccine using sendai virus as vector. Mycobacterium tuberculosis, and ... |
|
Invention
|
Anti-mycobacterium tuberculosis vaccine using sendai virus as vector. Provided in the present inv... |
|
Invention
|
Method for production of reprogrammed cell using chromosomally unintegrated virus vector. An obje... |
2015
|
Invention
|
Improved negative-strand rna viral vector. The present invention addresses the problem of providi... |
|
Invention
|
Production method for myocardium-like cells, and composition for production of myocardium-like ce... |
|
Invention
|
Lentiviral vectors. This invention relates to lentiviral gene transfer vectors pseudotyped with h... |
2014
|
Invention
|
Method for improving efficiency of inducing pluripotent stem cell. The present invention provides... |
|
Invention
|
Method for improving efficiency of inducing pluripotent stem cell. The present invention provide... |
2012
|
Invention
|
Pluripotent stem cell-derived brown adipocytes, pluripotent stem cell-derived cell aggregate, met... |
2010
|
P/S
|
Chemical reagents (other than for medical or veterinary
purposes); proteins (raw material); enzy... |
|
P/S
|
Chemical reagents not for medical or veterinary purposes; [ protein in raw material form for scie... |
2005
|
Invention
|
Methods for producing minus-strand rna viral vectors using hybrid promoter comprising cytomegalov... |
|
Invention
|
Method for producing minus-strand rna viral vectors using hybrid promoter comprising cytomegalovi... |